Krithika N. Kodumudi

Author

Also Known As

Jennifer Morse, K Kodumudi, K.N. Kodumudi, Krithika Kodumudi, Krithika Kodumudi, Krithika N Kodumudi, Krithika N. Kodumudi, Krithika Nandakumar Kodumudi, KrithikaN Kodumudi

104

Publications

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center University of Pennsylvania University of South Florida Indiana University – Purdue University Indianapolis Tianjin Medical University Cancer Institute and Hospital

About

Krithika N. Kodumudi is an author at Moffitt Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	788
2	Immunology	11	11	788
3	Cell Biology	5	5	499
4	Allergy	1	1	37
5	Cellular Therapies	1	1	109

Krithika N. Kodumudi

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy Shari Pilon‐Thomas, Krithika N. Kodumudi, Asmaa El-Kenawi, Cancer Research	2016	565
A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers Krithika N. Kodumudi, Karrune Woan, Danielle L. Gilvary, Clinical Cancer Research	2010	495
Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions Junmin Zhou, Jinfeng Wu, Xianghong Chen, International Immunopharmacology InflammationSuppressive CellsCytokineMedicineImmunology	2011	175
T-cells produce acidic niches in lymph nodes to suppress their own effector functions Hao Wu, Verónica Estrella, Matthew Beatty, Nature Communications	2020	146
Blockade of Myeloid-Derived Suppressor Cells after Induction of Lymphopenia Improves Adoptive T Cell Therapy in a Murine Model of Melanoma Krithika N. Kodumudi, Amy Weber, Amod A. Sarnaik, The Journal of Immunology Cell TherapyT-regulatory CellImmunologyImmune Cell TherapyImmunotherapy	2012	109
Intralesional rose bengal in melanoma elicits tumor immunity<i>via</i>activation of dendritic cells by the release of high mobility group box 1 Hao Liu, Patrick Innamarato, Krithika N. Kodumudi, Oncotarget ImmunologyRose BengalImmunologic MechanismImmunotherapyCancer Biology	2016	75
Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome Mythily Srinivasan, Krithika N. Kodumudi, Susan L. Zunt Clinical Immunology InflammationAutoimmune DiseaseMedicineOral CavityPathogenesis	2007	74
Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus Srihari B. Janardhanam, Sivaraman Prakasam, Venkatesh Swaminathan, Archives of Oral Biology Molecular ImmunologyDifferential ExpressionInnate Immune SystemImmunologyOral Biology	2011	70
Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy Krithika N. Kodumudi, Jessica A. Siegel, Amy Weber, PLoS ONE ImmunologyImmune RegulationImmunoeditingImmunotherapeuticsCd4 T Cell Responses	2016	70
Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma Tomar Ghansah, Nasreen A. Vohra, Kathleen Kinney, Cancer Immunology Immunotherapy Dendritic Cell ImmunotherapyTumor ImmunologyPancreatic CancerCancer ImmunosurveillanceMedicine	2013	68

Page 1